Abstract Details

Title Intravenous Recombinant Tissue Plasminogen Activator Administered at 3 to 6 Hours Following Onset of Ischemic Stroke Does Not Improve Outcome. A Meta-Analysis

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 129

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Samuel J. Maiser, MD (Hennepin Healthcare)	Dr. Maiser has nothing to disclose.
	No disclosure on file
	No disclosure on file
Alexandros L. Georgiadis, MD (MCALLEN MEDICAL CENTER)	No disclosure on file
	No disclosure on file
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��